Company Overview and News
Investors do not like the premium in terms of the book value and elevated earnings multiple, combined with aggressive synergy targets.
Filed Pursuant to Rule 433 Registration No. 333-213265-01 Market-Linked Step Up Notes
As shares of General Electric Company (NYSE:GE) have plunged, the calls for a breakup have grown louder. Bulls see the true value of GE stock as clouded by issues at GE Capital and weakness in divisions such as Lighting and Transportation. With two still-growing businesses — Aviation and Healthcare — plus a 62.5% stake in Baker Hughes a GE Co (NYSE:BHGE), optimists argue there has to be some value in General Electric stock, particularly after a 50%-plus decline from 2016 highs.
Wells Fargo (NYSE:WFC) has faced a slew of issues over the past couple of years that have been problematic and detrimental to the company. From opening an abundance of fake customer accounts, to their most recent scandal of charging customers for unnecessary auto insurance and fees for lower mortgage interest rates, Wells Fargo has damaged their reputation and been slapped with $1.185B in fines since 2016.
FIS has seen some recent improvements in organic growth, but the margin leverage has been more impressive.
When volatility picks up, investors flock to safety. It’s not a recent investment thesis or one derived from algorithmic trading. It’s a long-time reaction that’s generally driven by human psychology. As fears rise, investors first seek cash and then look for safe high-yield investments.
Markets closed lower on Friday as trade negotiations between the United States and China continued to weigh on investors’ sentiment. Also, bond yields reached their highest level since 2011 last week. Bank stocks in particular took a hit. The S&P 500 and Nasdaq closed in the red, while the Dow barely managed to end the day higher.
This article is part of a series that provides an ongoing analysis of the changes made to David Tepper’s 13F portfolio on a quarterly basis. It is based on Appaloosa Management’s regulatory 13F Form filed on 05/15/2018. Please visit our Tracking David Tepper’s Appaloosa Management Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q4 2017.
Bank of America Corp (NYSE:BAC) announced that it has rolled out a new virtual assistant called Erica, which is powered by artificial intelligence.
Over the last five trading days, banking stocks put up a lackluster show. Though improving U.S. economic data and rising 10-year Treasury bond yields were positives, investors were a bit concerned on the time uncertainty related to the easing of banking regulations and soft loan growth. Nevertheless, strong economy and increasing commodity prices aided a rise in bond yields followed by mortgage rates.
Pricing Supplement Filed Pursuant to Rule 424(b)(2) (To Prospectus dated May 1, 2015
Pricing Supplement (To Prospectus dated May 1, 2015 Filed Pursuant to Rule 424(b)(2)
The landmark court decision unleashes what could be a $150 billion industry within the next five years.
U.S. stock futures are battling higher this morning. Wall Street faces some stiff headwinds, but sentiment remains largely positive.
The largest three positions are Alliance Data Systems, Charles Schwab, and Alphabet, and they add up to ~42% of the portfolio.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET